Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: results from ms paths

被引：0
|
作者：
Hersh, C. [1 ]
Kieseier, B. [2 ]
De Moor, C. [2 ]
Miller, D. [3 ]
Campagnolo, D. [2 ]
Williams, J. [2 ]
Fitzgerald, K. [4 ]
Xiong, K. [2 ]
Mcginley, M. [3 ]
Hyland, M. [5 ]
Rudick, R. [2 ]
Ziemssen, T. [6 ,7 ]
Koulinska, I. [2 ]
机构：
[1] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Mellen Program MS, Las Vegas, NV USA
[2] Biogen, Cambridge, MA USA
[3] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[5] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14627 USA
[6] Univ Clin Carl Gustav Carus, Multiple Sclerosis Ctr, Dresden, Germany
[7] Univ Clin Carl Gustav Carus, Neuroimmunol Lab, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1036
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [1] Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS
    Hersh, Carrie M.
    Kieseier, Bernd
    de Moor, Carl
    Miller, Deborah M.
    Campagnolo, Denise
    Williams, James R.
    Fitzgerald, Kathryn C.
    Xiong, Kuangnan
    McGinley, Marisa P.
    Hyland, Megan
    Rudick, Richard A.
    Ziemssen, Tjalf
    Koulinska, Irene
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [2] Impact of Natalizumab on Quality of Life in a Real-World Cohort of Patients With Multiple Sclerosis: Results from MS Partners Advancing Technology and Health Solutions (MS PATHS)
    Hersh, Carrie M.
    Kieseier, Bernd
    De Moor, Carl
    Miller, Deborah M.
    Campagnolo, Denise
    Williams, James R.
    Fitzgerald, Kathryn C.
    Xiong, Kuangnan
    McGinley, Marisa P.
    Hyland, Megan
    Rudick, Richard A.
    Ziemssen, Tjalf
    Koulinska, Irene
    NEUROLOGY, 2021, 96 (15)
  • [3] Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Na Young
    Hyun, Jae-Won
    Kim, Ho Jin
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [4] Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
    Verkkoniemi-Ahola, Auli
    Hartikainen, Paivi
    Hassi, Katja
    Kuusisto, Hanna
    Lahdenpera, Sanni
    Mehtala, Juha
    Viitala, Matias
    Ylisaukko-oja, Tero
    Soilu-Hanninen, Merja
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (04)
  • [5] Impact of Natalizumab on Economic and Clinical Outcomes in MS Patients in the Real-World Setting
    Cai, Qian
    Tan, Hiangkiat
    Agarwal, Sonalee
    Kamat, Siddhesh
    NEUROLOGY, 2010, 74 (09) : A65 - A65
  • [6] Real-world multiple sclerosis in Brazil: Patterns of natalizumab therapy
    Alves, Monique
    Carvalho, Fabricio
    Ferreira, Diana
    Rahal, Elaine
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 159 - 159
  • [7] IMPACT OF BLEEDS ON THE QUALITY OF LIFE OF PATIENTS WITH HAEMOPHILIA: RESULTS FROM A MULTINATIONAL REAL-WORLD SURVEY
    Thakkar, S.
    Wilcox, L.
    Merla, V
    Kane, A.
    Alvir, J.
    Pemmaraju, S.
    Morton, E.
    Garratt-Wheeldon, J.
    Ball, N.
    Olsen, S.
    Golden, K.
    VALUE IN HEALTH, 2023, 26 (12) : S515 - S515
  • [8] Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
    Ysrraelit, Maria Celica
    Caride, Alejandro
    Sinay, Vladimiro
    Rivera Kindel, Mario
    Halfon, Mario Javier
    Patrucco, Liliana
    Piedrabuena, Raul
    Diaz Aragunde, Vanina Eleonor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (05) : 407 - 414
  • [9] Safety and effectiveness of natalizumab in a real-world multiple sclerosis Portuguese population
    Sequeira, M.
    Ferro, M.
    Barros, A.
    Sousa, A.
    Sequeira, J.
    Parra, J.
    Brum, M.
    Pedrosa, R.
    Capela, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 868 - 869
  • [10] Comparable efficacy of natalizumab EID and SID on neuroperformance measures in RRMS: real-world evidence from MS PATHS
    Ryerson, L. Zhovtis
    Naismith, R.
    Krupp, L.
    Charvet, L.
    Liao, S.
    De Moor, C.
    Williams, J.
    Campbell, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 205 - 205
12345